RE:RE:RE:RE:Multiplechry200030 wrote: Yeah... Can wait 5 years for $50. But doubt it takes that long.
Watch what happens when we get BTD. coming shortly..!
chry200030...you will find this link interesting, the author(he has 38 years experience in high tech & biotech) discuss what happen after a company get BTD approval.
https://seekingalpha.com/article/4314267-real-value-of-breakthrough-therapy-designation In the first paragraph it is said " BTD usually increase valuation
significantly". In the last paragraph under "Investment summary".
It is said " It is clear that getting a BTD adds significant value to a company. Based on historical averages, a
pure play company with a BTD for a
significant population could be worth $8.3 billion ".
1) TLT is a pure play company(specialize in cancer treatments).
2) Bladder cancer has a significant population(573,000 new patients worldwide each year).
$8 billion is a very big number, but if the BCG shortage persist and because TLT-Ruvidar has no side effects and can treat 100% of patients(no restrictions), TLT could get a resonable chunk of this $8 billion.